OBJECTIVETo assess the incidence of remission of type 2 diabetes in routine care settings.RESEARCH DESIGN AND METHODSPeople...
Auteur - American Diabetes Association - Care
Dasiglucagon Effectively Mitigates Postbariatric Postprandial...
OBJECTIVETo investigate the efficacy and safety of dasiglucagon, a novel stable glucagon analog in a liquid formulation, in...
The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested...
OBJECTIVETo investigate the mechanism for increased ketogenesis following treatment with the SGLT2 inhibitor dapagliflozin...
Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and...
OBJECTIVEPostpancreatitis diabetes mellitus (PPDM) is a frequent complication of pancreatitis and associates with poor...
Effects of Intensive Lifestyle Intervention on All-Cause Mortality in...
OBJECTIVELook AHEAD, a randomized trial comparing intensive lifestyle intervention (ILI) and diabetes support and education...
Sodium–Glucose Cotransporter 2 Inhibitor–Linked Pericolonoscopy...
Patients with type 2 diabetes (T2D) on sodium–glucose cotransporter 2 inhibitors (SGLT2i) may be at increased risk of...
Social Determinants of Health in U.S. Counties Where Guideline...
Social determinants of health (SDOH) strongly influence the development and progression of diabetes (1). As SDOH are...
Utility of Diabetes Type–Specific Genetic Risk Scores for the...
OBJECTIVEGenetic risk scores (GRS) aid classification of diabetes type in White European adult populations. We aimed to...
Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Bladder and...
There are concerns that sodium–glucose cotransporter 2 (SGLT2) inhibitors may increase risk of bladder cancer. Such an...
Association Between High-Deductible Health Plans and Engagement in...
OBJECTIVEHigh-deductible health plans (HDHPs) are increasingly more common but can be challenging for patients to navigate...